KawaguchiY., KawanishiH., MujaisS., TopleyN., OreopoulosD.G.Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis.Perit Dial Int2000; 20(Suppl 4): S43–55.
2.
KawaguchiY., SaitoA., KawanishiH., NakayamaM., MiyazakiM., NakamotoH.Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures.Perit Dial Int2005; 25(Suppl 4): S83–95.
KawanishiH., KawaguchiY., FukuiH., HaraS., ImadaA., KuboH.Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study.Am J Kidney Dis2004; 44: 729–37.
5.
BoulangerE., WautierM.P., GaneP., MarietteC., DevuystO., WautierJ.L.The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products.Nephrol Dial Transplant2004; 19: 2208–16.
6.
BoulangerE., WautierM.P., WautierJ.L., BovalB., PanisY., WernertN.AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression.Kidney Int2002; 61: 148–56.
7.
NumataM., NakayamaM., HosoyaT., HoffC.M., HolmesC.J., SchallingM.Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients.Clin Nephrol2004; 62: 455–60.
8.
CherneyD.Z., SiccionZ., ChuM., BargmanJ.M.Natural history and outcome of incarcerated abdominal hernias in peritoneal dialysis patients.Adv Perit Dial2004; 20: 86–9.
